Summary:
Click image to enlargeAssess the efficacy, safety, and tolerability of injection in adult subjects with moderate-to-severe atopic dermatitis.
Qualified Participants Must:
• 18 years of age or older
Moderate to severe eczema
•
History of topical corticosteroid use for eczema
Qualified Participants May Receive:
Compensation for time and travel for every completed visit
Study has 10 study visits over an estimated 30-week period.